Home / Pharmaceuticals / ADHD Drugs Market By Drug Type (Stimulant, Non-stimulant) By Age-Group (Adult (Aged 18 and above), Children) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy): Growth, Future Prospects, and Competitive Analysis, 2015 - 2027

ADHD Drugs Market By Drug Type (Stimulant, Non-stimulant) By Age-Group (Adult (Aged 18 and above), Children) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy): Growth, Future Prospects, and Competitive Analysis, 2015 - 2027

Published: Apr 2021 | Report Code: 60325-04-21

The Attention-Deficit Hyperactivity Disorder (ADHD) Drugs Market is expected to cross market value of USD 34,781 million in 2027 from USD 19,523 million in 2020. It is expected to grow at a CAGR of over 8.7% during the forecast period.

Global ADHD Drugs Market

Key Market Drivers and Restraints

Rising awareness regarding ADHD drugs among physicians, patients, and other healthcare providers is expected to drive the growth of the global ADHD Drugs market. Also, increasing number of clinical trials, and rising awareness regarding diagnosis and treatment of the condition is projected to fuel the growth of the global market over the forecast period.

However, under diagnosis of ADHD due to existence of comorbid conditions in children, low availability and lack of awareness of non-stimulant drugs to treat ADHD in various regions are expected to hamper the global ADHD drugs market.

Global ADHD Drugs Market

Impact of COVID 19

The Attention-Deficit Hyperactivity Disorder drug market will show considerable growth on the back of the global pandemic. As a result of the COVID-19 outburst, healthcare organizations have deprioritized the best part of non-essential medical treatments. Furthermore, with supply chain disruptions and delayed production lines, players are leveraging the demand for medicines, and are difficult to dispatch them to stores that are running out of necessary medicines.

Global ADHD Drugs Market

North America to Dominate the global ADHD Drugs Market

The global ADHD Drugs Market covers the six regions, namely Europe, North America, Asia Pacific, Latin America (LATAM), Middle East and Africa, including all the key economies in these regions. North America market is dominated the global market and accounted for more than 62.0% of the total market. This is attributed to the large volume of drug prescriptions, increasing product launches, and rising collaboration among players to enhance market penetration.

Global ADHD Drugs Market

Global ADHD Drugs Market is led by the Adult (Aged 18 and above)

Adult (Aged 18 and above), and Children, are the key age-group in the ADHD Drugs Market. In 2020, Adult (Aged 18 and above) segment is accounted for the largest share of ADHD Drugs Market. However, Children segment is anticipated to grow at the fastest CAGR during the forecast period.

Stimulant would continue to dominate the global ADHD Drugs Market in terms of Drug Type

Stimulant and Non-stimulant are some of the major types of drug type. Stimulant segment accounted for the largest share in 2020 of the ADHD Drugs Market in 2020. Increasing demand for stimulant drugs due to their effectiveness in treating symptoms of attention-deficit disorder, government imitative for the use of stimulants, and ongoing clinical trials.

Global ADHD Drugs Market

Frequently asked questions about global ADHD drugs market

  • What are the consequences of COVID 19 on global ADHD Drugs?
    Ans: The effect is vulnerability to distress caused by the current pandemic
  • Which are the key drug types through ADHD Drugs?
    Ans: Stimulant and Non-stimulant are the most frequently through ADHD Drugs
  • Which is the key age-group through which ADHD Drugs occurs?
    Ans: Adult (Aged 18 and above) is the most age-group in ADHD Drugs
  • Who are the key players in the global ADHD Drugs ?
    Ans: Amneal Pharmaceuticals, Inc, Eli Lilly And Company, Janssen Pharmaceuticals, Inc, Noven Pharmaceuticals, Inc, RespireRx Pharmaceuticals Inc, Otsuka Pharmaceutical Co., Ltd are key players operating in this market
  • Which is the fastest growing Distribution Channel segment for global ADHD Drugs?
    Ans: Retail Pharmacy Distribution Channel offers tremendous opportunities to players
  • Which is the leading regional market for global ADHD Drugs?
    Ans: North America has the largest share owing to high awareness of mental health, local presence of market players and increasing patient population
  • What will be the CAGR (2021 - 2027) of in global ADHD Drugs?
    Ans: The market is anticipated to grow at a CAGR of 8.7% throughout the forecast period
  • Which are the major factors driving the growth of global ADHD Drug?
    Ans: Rising incidence of ADHD and increasing access to health insurance for mental health treatment key driving factors propelling the growth of this market

Table of Content

1.Preface

1.1.Report Description
1.1.1.Purpose of the Report
1.1.2.Target Audience
1.1.3.USP and Key Offerings
1.2.Research Scope
1.3.Research Methodology
1.3.1.Phase I – Secondary Research
1.3.2.Phase II – Primary Research
1.3.3.Phase III – Expert Panel Review
1.3.4.Approach Adopted
1.3.4.1.Top-Down Approach
1.3.4.2.Bottom-Up Approach
1.3.5.Assumptions
1.4.Market Segmentation

2.Executive Summary

2.1.Market Snapshot: Global ADHD Drugs Market

3.Market Dynamics

3.1.Introduction
3.1.1. Global ADHD Drugs Market Value, 2015-2027, (US$ Bn)
3.2.Market Dynamics
3.2.1.Key Growth Trends
3.2.2.Major Industry Challenges
3.2.3.Key Growth Pockets
3.3.Attractive Investment Proposition,2020
3.3.1.Drug Type
3.3.2.Age-Group
3.3.3.Distribution Channel
3.3.4.Geography

4.Market Positioning of Key Players, 2020

4.1.Company market share of key players, 2020
4.2.Top 6 Players
4.3.Top 3 Players
4.4.Major Strategies Adopted by Key Players

5.COVID 19 Impact Analysis

5.1.Global ADHD Drugs Market Pre Vs Post COVID 19, 2019 - 2027
5.2.Impact on Import & Export
5.3.Impact on Demand & Supply

6.North America

6.1.North America ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
6.1.1.U.S.
6.1.2.Canada
6.1.3.Mexico
6.2.North America ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
6.2.1.Overview
6.2.2.Stimulant
6.2.3.Non-stimulant
6.3.North America ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
6.3.1.Overview
6.3.2.Adult (Aged 18 and above)
6.3.3.Children
6.4.North America ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
6.4.1.Overview
6.4.2.Retail Pharmacy
6.4.3.Hospital Pharmacy

7.Europe

7.1.Europe ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
7.1.1.UK
7.1.2.France
7.1.3.Germany
7.1.4.Italy
7.1.5.Russia
7.1.6.Spain
7.1.7.Belgium
7.1.8.Netherland
7.1.9.Austria
7.1.10.Sweden
7.1.11.Poland
7.1.12.Denmark
7.1.13.Switzerland
7.1.14.Rest of Europe
7.2.Europe ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
7.2.1.Overview
7.2.2.Stimulant
7.2.3.Non-stimulant
7.3.Europe ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
7.3.1.Overview
7.3.2.Adult (Aged 18 and above)
7.3.3.Children
7.4.Europe ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
7.4.1.Overview
7.4.2.Retail Pharmacy
7.4.3.Hospital Pharmacy

8.Asia Pacific

8.1.Asia Pacific ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
8.1.1.China
8.1.2.Japan
8.1.3.South Korea
8.1.4.India
8.1.5.Australia
8.1.6.New Zealand
8.1.7.Taiwan
8.1.8.Southeast Asia
8.1.9.Central Asia
8.1.10.Rest of Asia Pacific
8.2.Asia Pacific ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
8.2.1.Overview
8.2.2.Stimulant
8.2.3.Non-stimulant
8.3.Asia Pacific ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
8.3.1.Overview
8.3.2.Adult (Aged 18 and above)
8.3.3.Children
8.4.Asia Pacific ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
8.4.1.Overview
8.4.2.Retail Pharmacy
8.4.3.Hospital Pharmacy

9.Latin America

9.1.Latin America ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
9.1.1.Brazil
9.1.2.Argentina
9.1.3.Peru
9.1.4.Chile
9.1.5.Colombia
9.1.6.Rest of Latin America
9.2.Latin America ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
9.2.1.Overview
9.2.2.Stimulant
9.2.3.Non-stimulant
9.3.Latin America ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
9.3.1.Overview
9.3.2.Adult (Aged 18 and above)
9.3.3.Children
9.4.Latin America ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
9.4.1.Overview
9.4.2.Retail Pharmacy
9.4.3.Hospital Pharmacy

10.Middle East

10.1.Middle East ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
10.1.1.UAE
10.1.2.KSA
10.1.3.Israel
10.1.4.Turkey
10.1.5.Iran
10.1.6.Rest of Middle East
10.2.Middle East ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
10.2.1.Overview
10.2.2.Stimulant
10.2.3.Non-stimulant
10.3.Middle East ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
10.3.1.Overview
10.3.2.Adult (Aged 18 and above)
10.3.3.Children
10.4.Middle East ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
10.4.1.Overview
10.4.2.Retail Pharmacy
10.4.3.Hospital Pharmacy

11.Africa

11.1.Africa ADHD Drugs Market, by Country, 2015-2027(US$ Bn)
11.1.1.South Africa
11.1.2.Egypt
11.1.3.Nigeria
11.1.4.Rest of Africa
11.2.Africa ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
11.2.1.Overview
11.2.2.Stimulant
11.2.3.Non-stimulant
11.3.Africa ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
11.3.1.Overview
11.3.2.Adult (Aged 18 and above)
11.3.3.Children
11.4.Africa ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
11.4.1.Overview
11.4.2.Retail Pharmacy
11.4.3.Hospital Pharmacy

12.Global

12.1.Global ADHD Drugs Market, by Drug Type, 2015-2027(US$ Bn)
12.1.1.Overview
12.1.2.Stimulant
12.1.3.Non-stimulant
12.2.Global ADHD Drugs Market, By Age-Group, 2015-2027(US$ Bn)
12.2.1.Overview
12.2.2.Adult (Aged 18 and above)
12.2.3.Children
12.3.Global ADHD Drugs Market, by Distribution Channel, 2015-2027(US$ Bn)
12.3.1.Overview
12.3.2.Retail Pharmacy
12.3.3.Hospital Pharmacy

13.Company Profiles

13.1.Amneal Pharmaceuticals, Inc
13.2.Eli Lilly And Company
13.3.Janssen Pharmaceuticals, Inc
13.4.Noven Pharmaceuticals, Inc
13.5.RespireRx Pharmaceuticals Inc
13.6.Otsuka Pharmaceutical Co., Ltd
13.7.Neos Therapeutics, Inc.
13.8.American Brivision (Holding) Corporation
13.9.Novartis International AG
13.10.Takeda Pharmaceutical Company Limited
13.11.GlaxoSmithKline plc
13.12.Purdue Pharma L.P

List of Figures

FIG. 1 Global ADHD Drugs Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global ADHD Drugs Market Segmentation
FIG. 4 Global ADHD Drugs Market, by Product, 2019 (US$ Bn)
FIG. 5 Global ADHD Drugs Market, by End-user, 2019 (US$ Bn)
FIG. 6 Global ADHD Drugs Market, by Geography, 2019 (US$ Bn)
FIG. 7 Attractive Investment Proposition, by Geography, 2019
FIG. 8 Global Market Positioning of Key ADHD Drugs Market Manufacturers, 2019
FIG. 9 Global ADHD Drugs Market Value Contribution, By Drug Type, 2019 & 2027 (Value %)
FIG. 10 Global ADHD Drugs Market, by Metal 1, Value, 2015-2027 (US$ Bn)
FIG. 11 Global ADHD Drugs Market, by Metal 2, Value, 2015-2027 (US$ Bn)
FIG. 12 Global ADHD Drugs Market, by Metal 3, Value, 2015-2027 (US$ Bn)
FIG. 13 Global ADHD Drugs Market, by Metal 4, Value, 2015-2027 (US$ Bn)
FIG. 14 Global ADHD Drugs Market, by Metal 5, Value, 2015-2027 (US$ Bn)
FIG. 15 Global ADHD Drugs Market, by Others, Value, 2015-2027 (US$ Bn)
FIG. 16 Global ADHD Drugs Market Value Contribution, By Age-Group, 2019 & 2027 (Value %)
FIG. 17 Global ADHD Drugs Market, by Process 1, Value, 2015-2027 (US$ Bn)
FIG. 18 Global ADHD Drugs Market, by Process 2, Value, 2015-2027 (US$ Bn)
FIG. 19 Global ADHD Drugs Market, by Process 3, Value, 2015-2027 (US$ Bn)
FIG. 20 U.S. ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 21 Rest of North America ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 22 U.K. ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 23 Germany ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 24 France ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 25 Rest of Europe ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 26 Japan ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 27 China ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 28 India ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 29 Rest of Asia Pacific ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 30 Middle East & Africa ADHD Drugs Market, 2015-2027 (US$ Bn)
FIG. 31 Latin America ADHD Drugs Market, 2015-2027 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global ADHD Drugs Market
TABLE 2 Global ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 3 Global ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 4 Global ADHD Drugs Market, by Distribution Channel, 2015-2027 (US$ Bn)
TABLE 5 Global ADHD Drugs Market, by Geography, 2015-2027 (US$ Bn)
TABLE 6 North America ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 7 North America ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 8 North America ADHD Drugs Market, by Country, 2015-2027 (US$ Bn)
TABLE 9 Europe ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 10 Europe ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 11 Europe ADHD Drugs Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 12 Asia Pacific ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 13 Asia Pacific ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 14 Asia Pacific ADHD Drugs Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 15 Latin America ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 16 Latin America ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 17 Latin America ADHD Drugs Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 18 Middle East ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 19 Middle East ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 20 Middle East ADHD Drugs Market, by Country/Region, 2015-2027 (US$ Bn)
TABLE 21 Africa ADHD Drugs Market, by Drug Type, 2015-2027 (US$ Bn)
TABLE 22 Africa ADHD Drugs Market, by Age-Group, 2015-2027 (US$ Bn)
TABLE 23 Africa ADHD Drugs Market, by Country/Region, 2015-2027 (U$ Bn)
TABLE 24 Amneal Pharmaceuticals, Inc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Eli Lilly And Company: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26  Janssen Pharmaceuticals, Inc,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Noven Pharmaceuticals, Inc,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 RespireRx Pharmaceuticals Inc,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29  Otsuka Pharmaceutical Co., Ltd: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 30 , Neos Therapeutics, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 31 American Brivision (Holding) Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 32 Novartis International AG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 33 Takeda Pharmaceutical Company Limited: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 34 GlaxoSmithKline plc: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 35 Purdue Pharma L.P: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients